Renal cell cancer: what can we learn from pre-operative studies?

by Rosalie eFisher, James eLarkin
Published 2011-12-01

Inter and Intratumour heterogeneity: a barrier to individualised medical therapy in renal cell carcinoma?

by Rosalie eFisher, James eLarkin, Charles eSwanton
Published 2012-05-01

Sunitinib in mRCC: A systematic review of UK Real World Data

by David Andrew Montgomery, Miriam eArgyropulo-Palmer, Davinder eTheti, aron eJenkins, James eLarkin
Published 2015-08-01

Pazopanib-induced alopecia, an underestimated toxicity?

by Andrea eBiondo, Helen eAlexander, Komel eKhabra, Lisa ePickering, Martin eGore, James eLarkin
Published 2015-05-01

Observation as a treatment strategy for advanced renal cell carcinoma– a call for prospective validation.

by Rosalie eFisher, Alexandra ePender, Kiruthikah eThillai, Simon eChowdhury, Lisa ePickering, Komel eKhabra, Martin eGore, James eLarkin
Published 2012-10-01